Curiosity in metabolic drugs is growing, led by the favored class of weight administration drugs referred to as GLP-1 agonists. BioAge Labs goals to assist these medication work higher with a number one drug candidate proposed as a part of new GLP-1 mixture therapies. With a significant scientific trial already underway, BioAge has entered the general public market and raised […]